ESPEN guideline on chronic intestinal failure in adults - Update 2023.

Guideline Home parenteral nutrition Intestinal dysmotility Intestinal failure Intestinal transplantation Short bowel syndrome

Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
10 2023
Historique:
received: 09 07 2023
accepted: 21 07 2023
medline: 23 10 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: ppublish

Résumé

In 2016, ESPEN published the guideline for Chronic Intestinal Failure (CIF) in adults. An updated version of ESPEN guidelines on CIF due to benign disease in adults was devised in order to incorporate new evidence since the publication of the previous ESPEN guidelines. The grading system of the Scottish Intercollegiate Guidelines Network (SIGN) was used to grade the literature. Recommendations were graded according to the levels of evidence available as A (strong), B (conditional), 0 (weak) and Good practice points (GPP). The recommendations of the 2016 guideline (graded using the GRADE system) which were still valid, because no studies supporting an update were retrieved, were reworded and re-graded accordingly. The recommendations of the 2016 guideline were reviewed, particularly focusing on definitions, and new chapters were included to devise recommendations on IF centers, chronic enterocutaneous fistulas, costs of IF, caring for CIF patients during pregnancy, transition of patients from pediatric to adult centers. The new guideline consist of 149 recommendations and 16 statements which were voted for consensus by ESPEN members, online in July 2022 and at conference during the annual Congress in September 2022. The Grade of recommendation is GPP for 96 (64.4%) of the recommendations, 0 for 29 (19.5%), B for 19 (12.7%), and A for only five (3.4%). The grade of consensus is "strong consensus" for 148 (99.3%) and "consensus" for one (0.7%) recommendation. The grade of consensus for the statements is "strong consensus" for 14 (87.5%) and "consensus" for two (12.5%). It is confirmed that CIF management requires complex technologies, multidisciplinary and multiprofessional activity, and expertise to care for the underlying gastrointestinal disease and to provide HPN support. Most of the recommendations were graded as GPP, but almost all received a strong consensus.

Sections du résumé

BACKGROUND & AIMS
In 2016, ESPEN published the guideline for Chronic Intestinal Failure (CIF) in adults. An updated version of ESPEN guidelines on CIF due to benign disease in adults was devised in order to incorporate new evidence since the publication of the previous ESPEN guidelines.
METHODS
The grading system of the Scottish Intercollegiate Guidelines Network (SIGN) was used to grade the literature. Recommendations were graded according to the levels of evidence available as A (strong), B (conditional), 0 (weak) and Good practice points (GPP). The recommendations of the 2016 guideline (graded using the GRADE system) which were still valid, because no studies supporting an update were retrieved, were reworded and re-graded accordingly.
RESULTS
The recommendations of the 2016 guideline were reviewed, particularly focusing on definitions, and new chapters were included to devise recommendations on IF centers, chronic enterocutaneous fistulas, costs of IF, caring for CIF patients during pregnancy, transition of patients from pediatric to adult centers. The new guideline consist of 149 recommendations and 16 statements which were voted for consensus by ESPEN members, online in July 2022 and at conference during the annual Congress in September 2022. The Grade of recommendation is GPP for 96 (64.4%) of the recommendations, 0 for 29 (19.5%), B for 19 (12.7%), and A for only five (3.4%). The grade of consensus is "strong consensus" for 148 (99.3%) and "consensus" for one (0.7%) recommendation. The grade of consensus for the statements is "strong consensus" for 14 (87.5%) and "consensus" for two (12.5%).
CONCLUSIONS
It is confirmed that CIF management requires complex technologies, multidisciplinary and multiprofessional activity, and expertise to care for the underlying gastrointestinal disease and to provide HPN support. Most of the recommendations were graded as GPP, but almost all received a strong consensus.

Identifiants

pubmed: 37639741
pii: S0261-5614(23)00245-5
doi: 10.1016/j.clnu.2023.07.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1940-2021

Informations de copyright

Copyright © 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest The expert members of the working group were accredited by the ESPEN Guidelines Group, the ESPEN Education and Clinical Practice Committee, and the ESPEN executive. All expert members have declared their individual conflicts of interest according to the rules of the International Committee of Medical Journal Editors (ICMJE). If potential conflicts were indicated, they were reviewed by the ESPEN guideline officers and, in cases of doubts, by the ESPEN executive. None of the expert panel had to be excluded from the working group or from co-authorship because of serious conflicts. The conflict of interest forms are stored at the ESPEN guideline office and can be reviewed with legitimate interest upon request to the ESPEN executive.

Auteurs

Loris Pironi (L)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Center for Chronic Intestinal Failure, IRCCS AOUBO, Bologna, Italy. Electronic address: loris.pironi@unibo.it.

Cristina Cuerda (C)

Nutrition Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Palle Bekker Jeppesen (PB)

Rigshospitalet, Department of Gastroenterology, Copenhagen, Denmark.

Francisca Joly (F)

Center for Intestinal Failure, Department of Gastroenterology and Nutritional Support, Hôpital Beaujon, Clichy, France.

Cora Jonkers (C)

Nutrition Support Team, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands.

Željko Krznarić (Ž)

Center of Clinical Nutrition, Department of Medicine, University Hospital Center, Zagreb, Croatia.

Simon Lal (S)

Intestinal Failure Unit, Salford Royal Foundation Trust, Salford, United Kingdom.

Georg Lamprecht (G)

University Medical Center Rostock, Rostock, Germany.

Marek Lichota (M)

Intestinal Failure Patients Association "Appetite for Life", Cracow, Poland.

Manpreet S Mundi (MS)

Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, MN, USA.

Stéphane Michel Schneider (SM)

Gastroenterology and Clinical Nutrition, CHU of Nice, Université Côte d'Azur, Nice, France.

Kinga Szczepanek (K)

General and Oncology Surgery Unit, Stanley Dudrick's Memorial Hospital, Skawina, Poland.

André Van Gossum (A)

Department of Gastroenterology, HUB Erasme, Brussels, Belgium.

Geert Wanten (G)

Intestinal Failure Unit, Radboud University Medical Center, Nijmegen, the Netherlands.

Carolyn Wheatley (C)

Support and Advocacy Group for People on Home Artificial Nutrition (PINNT), United Kingdom.

Arved Weimann (A)

Department of General, Visceral and Oncological Surgery, St. George Hospital, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH